DE3107854A1 - 7-oxo-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeure-derivate, deren verwendung und herstellung - Google Patents

7-oxo-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeure-derivate, deren verwendung und herstellung

Info

Publication number
DE3107854A1
DE3107854A1 DE19813107854 DE3107854A DE3107854A1 DE 3107854 A1 DE3107854 A1 DE 3107854A1 DE 19813107854 DE19813107854 DE 19813107854 DE 3107854 A DE3107854 A DE 3107854A DE 3107854 A1 DE3107854 A1 DE 3107854A1
Authority
DE
Germany
Prior art keywords
group
hept
oxo
hydroxyethyl
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19813107854
Other languages
German (de)
English (en)
Inventor
Tetsuo Hiraoka
Noboru Ishida
Takeo Kobayashi
Shinichi Tokyo Sugawara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of DE3107854A1 publication Critical patent/DE3107854A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19813107854 1980-03-03 1981-03-02 7-oxo-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeure-derivate, deren verwendung und herstellung Withdrawn DE3107854A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2625480A JPS56122379A (en) 1980-03-03 1980-03-03 1-carba-2-penem-3-carboxylic acid derivative

Publications (1)

Publication Number Publication Date
DE3107854A1 true DE3107854A1 (de) 1982-02-25

Family

ID=12188121

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813107854 Withdrawn DE3107854A1 (de) 1980-03-03 1981-03-02 7-oxo-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeure-derivate, deren verwendung und herstellung

Country Status (15)

Country Link
US (1) US4377591A (enExample)
JP (1) JPS56122379A (enExample)
AU (1) AU6795681A (enExample)
BE (1) BE887752A (enExample)
DD (1) DD156911A5 (enExample)
DE (1) DE3107854A1 (enExample)
DK (1) DK93481A (enExample)
ES (1) ES8205225A1 (enExample)
FR (1) FR2477147B1 (enExample)
GB (1) GB2071656B (enExample)
IT (1) IT8167300A0 (enExample)
NL (1) NL8101039A (enExample)
PL (1) PL229973A1 (enExample)
SE (1) SE8101323L (enExample)
ZA (1) ZA811386B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
US4725594A (en) * 1984-12-13 1988-02-16 Merck & Co., Inc. Carbapenems having an internally or externally alkylated mono- or bicyclic 2-quaternary heteroarylalxyl heteromethyl substituent
US4729993A (en) * 1984-12-13 1988-03-08 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkyl substituent
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
EP0184844A1 (en) * 1984-12-13 1986-06-18 Merck & Co. Inc. 1-Methylcarbapenems having a 2-position substituent joined through an alkylenethio bridge
EP0186057A1 (en) * 1984-12-13 1986-07-02 Merck & Co. Inc. Carbapenems having a 2-position substituent joined through an alkyleneheteroatom bridge
US5068232A (en) * 1990-04-10 1991-11-26 American Cyanamid Company Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them
JPH05305569A (ja) * 1992-11-25 1993-11-19 Hitachi Ltd 表面研磨方法
JPH05305570A (ja) * 1992-11-25 1993-11-19 Hitachi Ltd 研磨部材
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218459A (en) * 1977-12-28 1980-08-19 Merck & Co., Inc. 6-Amido-1-carba-2-penem-3-carboxylic acid
US4203902A (en) * 1978-04-21 1980-05-20 Merck & Co., Inc. Process for preparing 6- and 2-substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
US4267188A (en) * 1979-08-09 1981-05-12 Merck & Co., Inc. 5-Substituted-1-carba-pen-2-em-3-carboxylic acid
US4262009A (en) * 1979-12-03 1981-04-14 Merck & Co., Inc. 6- And 1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acid

Also Published As

Publication number Publication date
ES500032A0 (es) 1982-06-01
PL229973A1 (enExample) 1981-10-30
ZA811386B (en) 1982-04-28
FR2477147B1 (enExample) 1983-11-25
AU6795681A (en) 1981-09-10
FR2477147A1 (enExample) 1981-09-04
JPS6237630B2 (enExample) 1987-08-13
DD156911A5 (de) 1982-09-29
BE887752A (fr) 1981-09-02
NL8101039A (nl) 1981-10-01
US4377591A (en) 1983-03-22
DK93481A (da) 1981-09-04
SE8101323L (sv) 1981-09-04
GB2071656B (en) 1984-02-15
ES8205225A1 (es) 1982-06-01
IT8167300A0 (it) 1981-03-03
GB2071656A (en) 1981-09-23
JPS56122379A (en) 1981-09-25

Similar Documents

Publication Publication Date Title
DE68919508T2 (de) 2-(Heterocyclylthio)carbapenemderivate, deren Herstellung und deren Verwendung als Antibiotika.
EP0003960B1 (de) 6-Substituierte Thia-Azaverbindungen, ihre Herstellung und diese enthaltende pharmazeutische Präparate
DE2726618C2 (enExample)
CH657853A5 (de) Carbapenemderivate, deren herstellung und solche verbindungen enthaltende praeparate.
DE2819655A1 (de) Thia-azaverbindungen mit beta- lactamring
DE3005164A1 (de) Antibiotisch wirksame beta -lactamverbindungen, verfahren zu deren herstellung und sie enthaltendes arzneimittel
DE3109086C2 (enExample)
US20030149016A1 (en) Novel carbapenem derivatives
DE3122523C2 (enExample)
US4377591A (en) 7-Oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives, their use and preparation
EP0041047A2 (de) Dioxidverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3317742C2 (enExample)
DE2912483A1 (de) Beta -lactamverbindungen, verfahren zu deren herstellung und arzneimittel
DE69807722T2 (de) Carbapenemderivate
EP0301394A1 (de) Stabile Oxapenem- 3-carbonsäuren
AT395590B (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
EP0246187A2 (de) 2-Pyridyl-penem-Verbindungen
DE3201957A1 (de) Derivate der 7-oxo-1-azabicyclo-(3.2.0)-hept-2-en-2-carbonsaeure
DE3752124T2 (de) Verfahren zur Herstellung von Penem Derivaten und Zwischenprodukte zu dieser Herstellung
EP0362622B1 (de) Verwendung stabiler Oxapenem-3-carbonsäuren zur Herstellung Beta-Lactamase hemmender Arzneimittel
DE60130916T2 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
DE69016719T2 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate und Zwischenverbindungen.
DE2254644A1 (de) Substituierte ceph-3-eme und ceph-3-em-sulfoxide und verfahren zu ihrer herstellung
DE2702552C2 (de) 7α-Methoxy-cephalosporine und Verfahren zur Herstellung derselben
DD223453A5 (de) Verfahren zur herstellung von 2-azacycloalkylthiopenem-derivaten

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: ZUMSTEIN SEN., F., DR. ASSMANN, E., DIPL.-CHEM. DR

8139 Disposal/non-payment of the annual fee